Cost-Effectiveness of Rivaroxaban and Aspirin Compared to Aspirin Alone in Patients with Stable Cardiovascular Disease- An Australian Perspective

Sep 1, 2018, 00:00
10.1016/j.jval.2018.07.013
https://www.valueinhealthjournal.com/article/S1098-3015(18)32369-6/fulltext
Title : Cost-Effectiveness of Rivaroxaban and Aspirin Compared to Aspirin Alone in Patients with Stable Cardiovascular Disease- An Australian Perspective
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)32369-6&doi=10.1016/j.jval.2018.07.013
First page :
Section Title :
Open access? : No
Section Order : 149
Categories :
Tags :
Regions :
ViH Article Tags :